Aclarion (ACON) Competitors $7.61 -0.14 (-1.81%) Closing price 04:00 PM EasternExtended Trading$7.56 -0.06 (-0.72%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ACON vs. ENZ, BRTX, MGRX, SSY, BGLC, VSEE, ATIP, DHAC, OTRK, and NIVFShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), VSee Health (VSEE), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), Ontrak (OTRK), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors Enzo Biochem Biorestorative Therapies Mangoceuticals SunLink Health Systems BioNexus Gene Lab VSee Health ATI Physical Therapy Digital Health Acquisition Ontrak NewGenIvf Group Enzo Biochem (NYSE:ENZ) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations. Which has more volatility & risk, ENZ or ACON? Enzo Biochem has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Aclarion has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Does the media prefer ENZ or ACON? In the previous week, Aclarion had 2 more articles in the media than Enzo Biochem. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Enzo Biochem. Aclarion's average media sentiment score of 0.20 beat Enzo Biochem's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment Enzo Biochem Neutral Aclarion Neutral Is ENZ or ACON more profitable? Enzo Biochem has a net margin of -75.34% compared to Aclarion's net margin of -12,227.10%. Enzo Biochem's return on equity of -7.96% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% Aclarion -12,227.10%-126.89%-106.61% Do insiders and institutionals believe in ENZ or ACON? 36.9% of Enzo Biochem shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 11.4% of Enzo Biochem shares are held by insiders. Comparatively, 0.8% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate ENZ or ACON? Aclarion has a consensus price target of $11,758.50, indicating a potential upside of 154,413.80%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aclarion 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings & valuation, ENZ or ACON? Aclarion has lower revenue, but higher earnings than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$29.09M0.59-$26.08MN/AN/AAclarion$54.60K81.12-$6.99MN/AN/A SummaryAclarion beats Enzo Biochem on 7 of the 13 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACON vs. The Competition Export to ExcelMetricAclarionMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.43M$7.19B$5.46B$8.92BDividend YieldN/A2.78%5.24%4.04%P/E RatioN/A27.3327.0120.12Price / Sales81.1233.47380.1493.34Price / CashN/A20.3926.2128.59Price / Book0.156.727.995.57Net Income-$6.99M$230.16M$3.16B$248.40M7 Day PerformanceN/A1.27%3.69%6.04%1 Month Performance10.77%2.35%2.90%7.69%1 Year Performance-99.71%46.16%34.30%20.97% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONAclarion2.1982 of 5 stars$7.61-1.8%$11,758.50+154,413.8%-99.7%$4.43M$54.60K0.007News CoverageENZEnzo BiochemN/A$0.33-14.8%N/A-69.3%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBiorestorative Therapies2.7638 of 5 stars$1.67+3.5%$18.00+980.7%-18.7%$12.49M$400K-1.137Gap UpMGRXMangoceuticals0.8461 of 5 stars$1.52-12.1%N/A-97.9%$7.86M$620K-0.333News CoveragePositive NewsGap DownSSYSunLink Health Systems0.9756 of 5 stars$0.88+0.6%N/A+27.5%$6.20M$31.09M6.291,376News CoveragePositive NewsBGLCBioNexus Gene Lab0.4155 of 5 stars$3.07+10.8%N/A+27.8%$5.53M$9.51M0.0030VSEEVSee Health1.199 of 5 stars$1.16+5.5%$5.00+331.0%N/A$4.18MN/A0.00N/AGap UpATIPATI Physical TherapyN/A$0.90+4.7%N/A-79.4%$3.97M$741.86M-0.055,600Gap UpDHACDigital Health AcquisitionN/A$1.10-3.5%N/A-86.8%$3.96MN/A0.002,021News CoverageGap DownOTRKOntrak2.8999 of 5 stars$0.50-9.8%$45.00+8,916.2%-85.7%$2.11M$10.85M-0.03250Gap DownHigh Trading VolumeNIVFNewGenIvf GroupN/A$1.04+1.0%N/A-99.6%$543K$5.43M0.00N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies Enzo Biochem Competitors Biorestorative Therapies Competitors Mangoceuticals Competitors SunLink Health Systems Competitors BioNexus Gene Lab Competitors VSee Health Competitors ATI Physical Therapy Competitors Digital Health Acquisition Competitors Ontrak Competitors NewGenIvf Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACON) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACON Stock Alerts